Skip to main content

Table 1 Demographic and treatment characteristics of the HIV positive SCD participants and identified HIV negative SCD controls analyzed to describe HIV outcomes and evaluate the association of HIV infection with SCD outcomes in Brazil

From: Association of HIV infection with clinical and laboratory characteristics of sickle cell disease

  HIV-positive
(n = 15)
HIV-negative
(n = 60)
P-value
Characteristics n (%) or mean ± SD  
Age (years)a 30.0 ± 13.0 30.9 ± 13.5 > 0.99
Gender    > 0.99
 Male 7 (47) 28 (47)  
 Female 8 (53) 32 (53)  
SCD genotype    > 0.99
 Hb SS 9 (60) 36 (60)  
 Hb SC 5 (33.3) 20 (33.3)  
 Hb Sβ + −thalassemia 1 (6.7) 4 (6.7)  
Hemocenter    0.94
 Hemorio 9 (60) 38 (63.3)  
 Hemominas-HBH 4 (26.7) 12 (20)  
 Hemominas-MOC 1 (6.7) 6 (10)  
 Hemope 1 (6.7) 4 (6.7)  
Hydroxyurea therapy    0.27
 Yes 1 (6.7) 14 (23.3)  
 No 14 (93.3) 46 (46.7)  
Chronic transfusion therapy    0.63
 Yes 3 (20) 7 (11.7)  
 No 12 (80) 53 (88.3)  
  1. aAge at time of enrollment or age when died for participants who had deceased. SD standard deviation; SCD sickle cell disease; HBH Hemocenter of Belo Horizonte; MOC Hemocenter of Montes Claros